Quarterly Result30 May 2026, 07:11 pm
Hindustan Bio Sciences FY26 Revenue at ₹73.71 Cr
AI Summary
Hindustan Bio Sciences Ltd's board approved the audited standalone financial results for the fourth quarter and financial year ended March 31, 2026. The company reported revenue from operations of ₹73.71 Cr for the year ended March 31, 2026, compared to ₹81.33 Cr in the previous year. The board also approved the appointment of Mr. GBK Viswanadham as an Internal Auditor for the financial year 2026-27.
Key Highlights
- Audited standalone financial results for FY26 approved.
- Revenue from operations stood at ₹73.71 Cr for FY26.
- GBK Viswanadham appointed as Internal Auditor for FY26-27.
- Auditors issued an unmodified opinion on the financial statements.
Price Impact
More from HINDBIO